CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Chronic Myelogenous Leukemia in Chronic Phase
Interventions
DRUG

Nilotinib

Nilotinib was supplied as 150 mg and 200 mg hard gelatin capsules.

Trial Locations (32)

10467

Montefiore Medical Center, The Bronx

14642

University of Rochester Medical Ct James P Wilmot Cancer Ctr, Rochester

21201

University of Maryland, Baltimore

22908

University of Virginia, Charlottesville

27710

Duke University Medical Center Duke University Med Ctr, Durham

29605

Cancer Centers of the Carolinas Cancer Center, Greenville

30912

Georgia Regents University MedCollege of GA Cancer Ctr 2, Augusta

32256

Sarah Cannon Research Institute SCRI, Jacksonville

33176

Advanced Medical Specialties, Miami

34652

Pasco Hernando Oncology, New Port Richey

37203

Tennessee Oncology Sarah Cannon Research Inst., Nashville

37404

Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga

38138

The Jones Clinic, Germantown

46107

Indiana Blood and Marrow Institute, Beach Grove

48202

Henry Ford Hospital, Detroit

60612

Stroger Cook County Hospital Division of Hematology & Onc, Chicago

60640

Louis A. Weiss Memorial Hospital, Chicago

63110

St. Louis University Cancer Center, St Louis

68198

University of Nebraska Medical Center University of Nebraska Med Ctr, Omaha

70115

LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center(3), New Orleans

75204

Baylor Research Institute Baylor Research Institute (17), Dallas

77024

Oncology Consultants Oncology Consultants, P.A., Houston

77090

Millennium Oncology, Houston

92801

Pacific Cancer Medical Center, Inc., Anaheim

92886

St. Jude Heritage Medical Group Virginia Crosson Cancer Center, Yorba Linda

94520

Bay Area Cancer Research Dept.ofBayAreaCancerResearch, Concord

97201

Oregon Health & Science University, Portland

98201

Providence Regional Cancer Partnership, Everett

91505-6866

Providence St. Joseph Medical Center Roy&Patricia Disney Fam Cancer, Burbank

67214-3728

Cancer Center of Kansas, Witchita

02115

Dana Farber Cancer Institute, Boston

07601

Hackensack University Medical Center Dept.of HackensackUniv.MedCtr., Hackensack

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY